Alliance Pharma plc (APH) — Net Asset Momentum
Alliance Pharma plc (APH) recorded a net asset momentum of -4.7% as of December 2024, with net assets of GBX207.64 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Alliance Pharma plc (APH) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Alliance Pharma plc Net Asset Momentum (1999–2024)
This chart tracks Alliance Pharma plc's year-over-year net asset growth across 28 annual reporting periods from 1999 to 2024. The most recent momentum reading is -4.7%, with net assets of GBX207.64 Million GBX as of December 2024. Read APH total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Alliance Pharma plc (1999–2024)
The table below shows the complete annual net asset history for Alliance Pharma plc from 1999 to 2024, covering 28 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Alliance Pharma plc (APH) market capitalisation.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX207.64 Million | GBX369.14 Million | GBX161.50 Million | ▼ -4.7% |
| 2023 | GBX217.87 Million | GBX414.92 Million | GBX197.05 Million | ▼ -24.3% |
| 2022 | GBX287.66 Million | GBX537.41 Million | GBX249.75 Million | ▲ +1.8% |
| 2021 | GBX282.49 Million | GBX503.49 Million | GBX221.00 Million | ▲ +0.5% |
| 2020 | GBX280.96 Million | GBX508.85 Million | GBX227.90 Million | ▲ +2.5% |
| 2019 | GBX274.18 Million | GBX407.64 Million | GBX133.46 Million | ▲ +8.7% |
| 2018 | GBX252.20 Million | GBX403.61 Million | GBX151.41 Million | ▲ +24.0% |
| 2017 | GBX203.38 Million | GBX336.48 Million | GBX133.10 Million | ▲ +13.5% |
| 2016 | GBX179.26 Million | GBX320.74 Million | GBX141.47 Million | ▲ +10.4% |
| 2015 | GBX162.44 Million | GBX292.19 Million | GBX129.75 Million | ▲ +129.5% |
| 2014 | GBX70.78 Million | GBX107.87 Million | GBX37.09 Million | ▲ +9.5% |
| 2013 | GBX64.67 Million | GBX106.99 Million | GBX42.32 Million | ▲ +24.7% |
| 2012 | GBX51.85 Million | GBX100.63 Million | GBX48.78 Million | ▲ +17.5% |
| 2011 | GBX44.13 Million | GBX82.29 Million | GBX38.16 Million | ▲ +22.3% |
| 2010 | GBX36.08 Million | GBX77.40 Million | GBX41.32 Million | ▲ +117.0% |
| 2009 | GBX16.63 Million | GBX56.80 Million | GBX40.17 Million | ▲ +89.7% |
| 2008 | GBX8.77 Million | GBX48.83 Million | GBX40.07 Million | ▲ +31.5% |
| 2007 | GBX6.67 Million | GBX46.41 Million | GBX39.74 Million | ▼ -36.1% |
| 2006 | GBX10.43 Million | GBX48.07 Million | GBX37.63 Million | ▲ +39.0% |
| 2005 | GBX7.50 Million | GBX35.76 Million | GBX28.26 Million | ▲ +9.9% |
| 2005 | GBX6.83 Million | GBX34.30 Million | GBX27.47 Million | ▲ +206.7% |
| 2004 | GBX2.23 Million | GBX26.44 Million | GBX24.21 Million | ▲ +1246.9% |
| 2003 | GBX-194.00K | GBX20.82 Million | GBX21.01 Million | ▼ -108.7% |
| 2002 | GBX2.24 Million | GBX2.26 Million | GBX24.11K | ▲ +315.8% |
| 2002 | GBX538.00K | GBX8.82 Million | GBX8.29 Million | ▼ -9.6% |
| 2001 | GBX595.00K | GBX3.99 Million | GBX3.39 Million | ▲ +31.9% |
| 2000 | GBX451.00K | GBX4.35 Million | GBX3.90 Million | ▲ +295.6% |
| 1999 | GBX114.00K | GBX6.57 Million | GBX6.45 Million | — |